Recon: EMA recommends Novo's Wegovy for heartrisks; Mankind to buy Bharat Serums for $1.6B
Federal regulation of health data and AI expected to get a boost after HHS revamp (STAT); Astra Zeneca says there's 'very limited' impact on Farxiga …
- Topics
- Regulation & PolicyHealthcareGovernment & Public Sector
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”